Champions Oncology (CSBR) Cash & Equivalents Growth (1y) (2011 - 2026)
Champions Oncology (CSBR) Cash & Equivalents Growth (1y) (2011 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash & Equiv. Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
988.88% |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
-68.22% |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
0.00% |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
4.77% |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
3.35% |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
269.98% |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
17.50% |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
- |
| 10 |
Champions Oncology |
81.79 Mn |
74.79 Mn |
13.89 Mn |
121.74% |
| Date | Value |
|---|
| Jan 31, 2026 |
121.74% |
| Oct 31, 2025 |
209.22% |
| Jul 31, 2025 |
256.15% |
| Apr 30, 2025 |
273.76% |
| Jan 31, 2025 |
-28.84% |
| Oct 31, 2024 |
-50.05% |
| Jul 31, 2024 |
-40.98% |
| Oct 31, 2023 |
-49.08% |
| Jul 31, 2021 |
-42.39% |
| Jul 31, 2020 |
215.30% |
| Apr 30, 2020 |
157.71% |
| Jan 31, 2020 |
-0.85% |
| Jul 31, 2019 |
116.73% |
| Apr 30, 2019 |
278.15% |
| Jan 31, 2019 |
211.68% |
| Jul 31, 2018 |
154.00% |
| Apr 30, 2018 |
-74.02% |
| Jan 31, 2018 |
-69.55% |
| Oct 31, 2017 |
-83.83% |
| Jul 31, 2017 |
-91.04% |
